Seeking Alpha

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S....

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S. patent office for a patent covering the use of its NeuVax product candidate, a vaccine for inducing immunity to breast cancer recurrence in some patients. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)